Business Description
Encision Inc
NAICS : 339112
SIC : 3841
ISIN : US29254Q1040
Description
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally-invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.65 | |||||
| Debt-to-EBITDA | -4.81 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -4.02 | |||||
| Beneish M-Score | -2.89 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.9 | |||||
| 3-Year EBITDA Growth Rate | -166.8 | |||||
| 3-Year EPS without NRI Growth Rate | -14.5 | |||||
| 3-Year FCF Growth Rate | -54.8 | |||||
| 3-Year Book Growth Rate | 3.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 5.63 | |||||
| 9-Day RSI | 15.77 | |||||
| 14-Day RSI | 25.94 | |||||
| 6-1 Month Momentum % | 8.7 | |||||
| 12-1 Month Momentum % | 28.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.55 | |||||
| Quick Ratio | 1.08 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 190.63 | |||||
| Days Sales Outstanding | 49.01 | |||||
| Days Payable | 30.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | -4.91 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.55 | |||||
| Operating Margin % | -5.69 | |||||
| Net Margin % | -6.52 | |||||
| ROE % | -18.66 | |||||
| ROA % | -10.61 | |||||
| ROIC % | -10.61 | |||||
| ROC (Joel Greenblatt) % | -11.77 | |||||
| ROCE % | -12.26 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.77 | |||||
| PB Ratio | 2.32 | |||||
| Price-to-Tangible-Book | 2.59 | |||||
| Price-to-Operating-Cash-Flow | 220 | |||||
| EV-to-EBIT | -16.9 | |||||
| EV-to-EBITDA | -21.91 | |||||
| EV-to-Revenue | 0.95 | |||||
| EV-to-FCF | 99999999.99 | |||||
| Price-to-Median-PS-Value | 1.13 | |||||
| Price-to-Net-Current-Asset-Value | 8.8 | |||||
| Earnings Yield (Greenblatt) % | -5.92 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers